O'Brien, E.; Dave, D.; Kleckley, A.; Oladipo, F.; Mayer, C.M.; Henderson, R.; Vasquez, B.; Lucas, E.; Thomas, J.A.; Thomas, R.;
et al. Patient-Derived Microtumors: How Can We Continue to Personalize Treatment for Ovarian Cancer Patients? Targets 2026, 4, 2.
https://doi.org/10.3390/targets4010002
AMA Style
O'Brien E, Dave D, Kleckley A, Oladipo F, Mayer CM, Henderson R, Vasquez B, Lucas E, Thomas JA, Thomas R,
et al. Patient-Derived Microtumors: How Can We Continue to Personalize Treatment for Ovarian Cancer Patients? Targets. 2026; 4(1):2.
https://doi.org/10.3390/targets4010002
Chicago/Turabian Style
O'Brien, Emily, Dhruva Dave, Abbie Kleckley, Fibiana Oladipo, Christopher M. Mayer, Rebecca Henderson, Blanca Vasquez, Elizabeth Lucas, Jeffrey A. Thomas, Rony Thomas,
and et al. 2026. "Patient-Derived Microtumors: How Can We Continue to Personalize Treatment for Ovarian Cancer Patients?" Targets 4, no. 1: 2.
https://doi.org/10.3390/targets4010002
APA Style
O'Brien, E., Dave, D., Kleckley, A., Oladipo, F., Mayer, C. M., Henderson, R., Vasquez, B., Lucas, E., Thomas, J. A., Thomas, R., Singh, R., Chen, J., Toboni, M. D., Leath, C. A., III, & Arend, R. C.
(2026). Patient-Derived Microtumors: How Can We Continue to Personalize Treatment for Ovarian Cancer Patients? Targets, 4(1), 2.
https://doi.org/10.3390/targets4010002
